Mannkind Appoints Tony Hooper to its Board of Directors and Member of the Audit Committee, Effective January 1, 2020

MannKind Corporation announced that Anthony Hooper will join its Board of Directors, effective January 1, 2020.  Mr. Hooper will also serve as a member of the Audit Committee of the Board. Mr. Hooper brings 35 years of experience in the pharmaceutical industry to the MannKind Board of Directors. Hooper served as executive vice president of Global Commercial Operations for Amgen Inc. from October 2011 until August 2018.